|Bid||2.4800 x 800|
|Ask||2.4900 x 800|
|Day's Range||2.4600 - 2.5300|
|52 Week Range||1.1600 - 6.6400|
|Beta (5Y Monthly)||-0.53|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.57|
Subscribe to Yahoo Finance Plus to view Fair Value for WVE
Mirati (MRTX) delivered earnings and revenue surprises of 9.92% and 143.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Thursday, August 11, 2022, to discuss the company’s second quarter 2022 financial results and provide a business update. The webcast of the conference call may be accessed by visi
Over the last month the Wave Life Sciences Ltd. ( NASDAQ:WVE ) has been much stronger than before, rebounding by 94...